4//SEC Filing
ATLAS VENTURE ASSOCIATES X, L.P. 4
Accession 0001209191-21-042857
CIK 0001733294other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:26 PM ET
Size
33.3 KB
Accession
0001209191-21-042857
Insider Transaction Report
Form 4
ATLAS VENTURE ASSOCIATES X, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-06-21$25.12/sh−3,796$95,356→ 151,912 total - Sale
Common Stock
2021-06-21$25.12/sh−7$176→ 890 total(indirect: See footnote) - Sale
Common Stock
2021-06-22$25.20/sh−25,208$635,242→ 93,443 total - Sale
Common Stock
2021-06-23$25.08/sh−34,162$856,783→ 59,281 total - Sale
Common Stock
2021-06-23$25.69/sh−53$1,362→ 666 total(indirect: See footnote) - Sale
Common Stock
2021-06-22$24.76/sh−61$1,510→ 829 total(indirect: See footnote) - Sale
Common Stock
2021-06-23$25.08/sh−63$1,580→ 719 total(indirect: See footnote) - Sale
Common Stock
2021-06-22$24.76/sh−33,261$823,542→ 118,651 total - Sale
Common Stock
2021-06-22$25.20/sh−47$1,184→ 782 total(indirect: See footnote) - Sale
Common Stock
2021-06-21$24.82/sh−59,978$1,488,654→ 155,708 total - Sale
Common Stock
2021-06-21$24.82/sh−111$2,755→ 897 total(indirect: See footnote) - Sale
Common Stock
2021-06-23$25.69/sh−28,331$727,823→ 30,950 total
Footnotes (11)
- [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan dated April 20 ,2021.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.63 to $25.62 inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.63 to $25.95 inclusive.
- [F2]The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. for no additional consideration to its limited partners and its and general partner, Atlas Venture Associates X, L.P. ("AVA X LP"), subsequent to the Reporting Persons' last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distribution of such shares constituted only a change in the form of the Reporting Persons' ownership in such shares, the Reporting Persons were not required to report the distribution pursuant to Section 16.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.08 to $25.07 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5), (8), (9), (10) and (11).
- [F4]The shares are held directly by AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. AVA X LLC disclaims Section 16 beneficial ownership of the securities held by AVA X LP except to the extent of its pecuniary interest therein, if any.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.08 to $25.20 inclusive.
- [F6]The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Opportunity Fund I, L.P. for no additional consideration to its limited partners and its and general partner, Atlas Venture Associates Opportunity I, LP ("AVAO LP"), subsequent to the Reporting Persons' last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distribution of such shares constituted only a change in the form of the Reporting Persons' ownership in such shares, the Reporting Persons were not required to report the distribution pursuant to Section 16.
- [F7]The shares are held directly by AVAO LP. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVAO LP except to the extent of its pecuniary interest therein, if any.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.08 to $25.07 inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.10 to $25.285 inclusive.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001742766
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:26 PM ET
- Size
- 33.3 KB